Changes in Body Composition and Metabolic Risk Parameters by Life Style Intervention.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00356785
Recruitment Status : Completed
First Posted : July 26, 2006
Last Update Posted : July 26, 2006
Almased Wellness GmbH
Information provided by:
University Hospital Freiburg

Brief Summary:
Eligible overweight and obese persons will be randomized to one of three controlled groups: 1 group of participants is treated by health education for life style intervention only. The other 2 groups will be included in a dietary program with an individually dosed food supplement (Almased®) for an initial weight reduction for a period of 6 weeks. The following 18 weeks represent the most important phase of weight loss and attitude, the participants take part in 2 different interventions according to their randomization. One group will continue the dietary program, one group will try to achieve and maintain weight reduction by continuing the initial dietary program together with an additional physical activity program. For all intervention groups the following 6 months aim at a further stabilization of weight and attitude, now without defined guidelines of intervention but with the intention to continue the so far practiced change in life style. All participants will be supplied with adequate information and material concerning the desired change in life style.

Condition or disease Intervention/treatment Phase
Obesity Metabolic Syndrome Behavioral: health education Behavioral: food supplementation Behavioral: food supplementation combined with physical activity program Not Applicable

Detailed Description:

Obese and adipose participants are randomized to three intervention groups. During the first six weeks of the program, the subjects assigned to the substitutional diet group (SD-G) were instructed to replace two daily meals with a commercially available soy-joghurt-honey preparation (Almased®). During the following 18 weeks, only one daily meal was replaced by the preparation. The dietary intake of fat during this second phase was not to exceed 60g per day. The first 6-week diet contained about 1000 kcal per day for women and 1200 kcal for men, and then, in the following weeks, aimed at a maximum of 1500 kcal for women and 1700 kcal for men. In addition, a second group of subjects were encouraged to additionally attend a 60-minute physical activity endurance program twice weekly. Otherwise, they were to follow the same rules as the substitutional diet group (SD/PA-G).

The lifestyle education group (LE-G) attended, after enrolment, three teaching sessions bi-monthly and had individual consultations during weeks 6, 24 and 48. All sessions were held by experts in nutritional counselling. Subjects received a diet-overview handout, in accordance with the “German Society of Nutrition“ and the ”German Society of Sports Medicine and Prevention“. Prescribed was a moderate-fat, nutrient-balanced reduction diet consisting of 1200 to 1500 kcal per day for women and 1500 to 1800 kcal per day for men, with approximately 60 percent of the calories coming from carbohydrates, 25 percent from fat, and 15 percent from protein.

The data collected at enrolment and after 6, 24 and 48 weeks were body weight, waist and abdominal circumference, self-reported medical history, blood pressure, glucose, insulin, serum lipids and inflammatory markers (C-reactive protein, IL-6). For measurement of body composition, the technique of air displacement plethysmography was used (Bod Pod). Dietary compliance was estimated by 24-hour recalls of dietary consumption.

Endpoints: Body weight loss of 5% and 10 %; Reduction of body fat; Change of muscle mass

Study Type : Interventional  (Clinical Trial)
Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Body Compositional and Endocrine-Metabolic Changes by Long-Term Lifestyle Intervention With Health Education, Diet (Almased®), Physical Activity or a Combination of Diet and Physical Activity in Overweight and Obese Persons.
Study Start Date : January 2001
Study Completion Date : December 2001

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. body weight loss of more than 5%
  2. body weight loss of more than 10%

Secondary Outcome Measures :
  1. reduction of body fat
  2. change of muscle mass
  3. change in blood pressure
  4. change in lipids
  5. change in fasting blood glucose
  6. change in weight circumference

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   34 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Eligible participants must have overweight with a BMI between 27,5 and 35 kg/m²
  • The participants must be able to participate in a physical activity program
  • The participants must be willing to participate in the program for 1 year
  • Written informed consent must be given to accept randomization to either of the intervention groups

Exclusion Criteria:

  • Participants who do not meet all entry criteria
  • BMI > 35,0 kg / m²
  • Performance capacity < 75 w for 2 min
  • Subjects younger than 35 yrs (with reference age at 1st Jan 2002: 34.5 yrs) or older than 65 yrs (with reference age at 1st 2002: 65.5 yrs)
  • Absolute or relative contraindications to exercise testing of the ACSM
  • Persons unable or with restrictions to participate in a regular physical activity program because of any disease (e.g. history of CHD, arrhythmia, valvular heart disease, arthritis of major joints)
  • Severe hypertension systolic BP of > 200 mm Hg and or diastolic BP of > 105 mm Hg at rest
  • Persons with established insulin dependent diabetes mellitus (IDDM)
  • Persons with a disease of the liver or the kidneys prohibiting high protein intake
  • Persons with a disease of the thyroid gland or taking thyroid hormones

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00356785

University Hospital, Department for Rehabilitation, Prevention and Sports Medicine
Freiburg, Germany, 79106
Sponsors and Collaborators
University Hospital Freiburg
Almased Wellness GmbH
Study Director: Aloys Berg, Prof.Dr. University Hospital, Department for Rehabilitation, Prevention and Sports Medicine, Freiburg, Germany

Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number): Identifier: NCT00356785     History of Changes
Other Study ID Numbers: 230/01
First Posted: July 26, 2006    Key Record Dates
Last Update Posted: July 26, 2006
Last Verified: April 2006

Keywords provided by University Hospital Freiburg:
physical activity

Additional relevant MeSH terms:
Metabolic Syndrome X
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases